These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20424888)

  • 1. Enucleation for retinoblastoma: the experience of a single center in Jordan.
    Sultan I; Wilson MW; Nawaiseh I; Mehyar M; Kharma S; Al-Qudimat M; Hazin R; Alalami A; Jaradat I; Al-Husseini M; Abdeen G; Rodriguez-Galindo C; Qaddoumi I
    Int Ophthalmol; 2010 Aug; 30(4):407-14. PubMed ID: 20424888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.
    Al-Nawaiseh I; Jammal HM; Khader YS; Jaradat I; Barham R
    Ophthalmic Epidemiol; 2014 Dec; 21(6):406-11. PubMed ID: 25317653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
    Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
    Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
    J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of high risk pathological features between primary and secondary enucleation for retinoblastoma.
    Mohammad M; Shehada R; Al-Nawaiseh I; Mehyar M; AlHussaini M; Jaradat I; Sultan I; Halalsheh H; Khzouz J; Yousef YA
    Eur J Ophthalmol; 2023 Sep; 33(5):2014-2023. PubMed ID: 36760120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
    J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoreduction for unilateral retinoblastoma.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma].
    Deng X; Cheng Y; Zhu XM; Linghu DD; Zhao MW; Liang JH
    Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):681-687. PubMed ID: 32907301
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical manifestations and treatment of retinoblastoma in Kobe children's hospital for 16 years.
    Okimoto S; Nomura K
    J Pediatr Ophthalmol Strabismus; 2014 Jul; 51(4):222-9. PubMed ID: 24844394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
    Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
    Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Systemic Chemotherapy and Delayed Enucleation on Survival of Children with Advanced Intraocular Retinoblastoma.
    Zhao J; Feng ZX; Wei M; Liu G; Solarte CE; Li B; Wang Y; Zhang C; Gallie BL
    Ophthalmol Retina; 2020 Jun; 4(6):630-639. PubMed ID: 32387053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
    Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
    Shields CL; Shields JA
    Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.
    Künkele A; Jurklies C; Wieland R; Lohmann D; Bornfeld N; Eggert A; Schulte JH
    Br J Ophthalmol; 2013 Oct; 97(10):1277-83. PubMed ID: 23863458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.